Convatec Group PLC

CTEC: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
r#!LOCK|XPtQLOCK|qNly&d

Convatec Earnings: Continence and Infusion Care Lift Sales and Guidance; Shares Undervalued

Convatec's organic sales growth (excluding InnovaMatrix) accelerated in the second half of 2026, delivering 6.6% for the 10 months ended October. Growth was driven by continence and infusion, with the latter also supporting margin expansion. The share price jumped 9% at the market open on Nov. 18.

Sponsor Center